The Canadian government is requesting feedback relating to the renegotiation of the North American Free Trade Agreement. In particular, the government is asking for the public’s “views on the key areas in NAFTA that could be clarified or updated,
Health Canada seeks feedback on proposed regulatory amendments to PMPRB pricing regime of patented medicines
On May 16, 2017, Health Canada published a consulting paper titled “Protecting Canadians from Excessive Drug Prices.” The paper describes five proposed amendments to the Patented Medicines Regulations that are meant to help better assess whether the price of a
CETA tracker: CETA Bill C-30 receives royal assent to implement pharmaceutical patent reform
It’s official – the Canadian government has approved the changes to Canada’s pharmaceutical patent regime. On May 16, 2017, Bill C-30 (the act intended to implement CETA into Canadian law) received royal assent, the final stage of the legislative process.
CETA tracker: patent term restoration is coming soon to Canada – what you need to know now
Treaty/Act: CETA/Bill C-30 (An Act to implement the Comprehensive Economic and Trade Agreement between Canada and the European Union and its Member States and to provide for certain other measures)
With Canada moving closer towards implementing the Comprehensive